Better Therapeutics Commences Pivotal Study of Prescription Digital Therapeutic for the Treatment of Type 2 Diabetes | Business Wire businesswire.com/news/home/2…
With the astronomical and growing cost of care for patients with type 2 diabetes and other cardiometabolic conditions, patients, providers and payers all deserve therapeutics that address the root causes of disease, yet we continue to spend hundreds of... businesswire.com/news/home/2…
What drives success in Digital Therapeutics? #DTx
Most digital health solutions fail, or at least, never manage to scale up, very few succeed. What lessons can we learn from those who do it right? @r2guidanceresearch2guidance.com/what-d…